世界における先天的遺伝子変異または先天的染色体変異検査製品のパイプライン動向2015...市場調査レポートについてご紹介

【英文タイトル】Inborn Gene or Chromosome Alterations - Pipeline Review, 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 10
2 Introduction 11
2.1 Inborn Gene or Chromosome Alterations Overview 11
3 Products under Development 12
3.1 Inborn Gene or Chromosome Alterations – Pipeline Products by Stage of Development 12
3.2 Inborn Gene or Chromosome Alterations – Pipeline Products by Territory 13
3.3 Inborn Gene or Chromosome Alterations – Pipeline Products by Regulatory Path 14
3.4 Inborn Gene or Chromosome Alterations – Pipeline Products by Estimated Approval Date 15
3.5 Inborn Gene or Chromosome Alterations – Ongoing Clinical Trials 16
4 Inborn Gene or Chromosome Alterations – Pipeline Products under Development by Companies 17
4.1 Inborn Gene or Chromosome Alterations Companies – Pipeline Products by Stage of Development 17
4.2 Inborn Gene or Chromosome Alterations – Pipeline Products by Stage of Development 20
5 Inborn Gene or Chromosome Alterations Companies and Product Overview 23
5.1 AC-Gen Reading Life S.L. Company Overview 23
5.1.1 AC-Gen Reading Life S.L. Pipeline Products & Ongoing Clinical Trials Overview 23
5.2 Admera Health, LLC Company Overview 24
5.2.1 Admera Health, LLC Pipeline Products & Ongoing Clinical Trials Overview 24
5.3 Agena Bioscience, Inc Company Overview 25
5.3.1 Agena Bioscience, Inc Pipeline Products & Ongoing Clinical Trials Overview 25
5.4 Ariosa Diagnostics, Inc. Company Overview 29
5.4.1 Ariosa Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
5.5 Atomic International Company Overview 30
5.5.1 Atomic International Pipeline Products & Ongoing Clinical Trials Overview 30
5.6 Baylor College of Medicine Company Overview 31
5.6.1 Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 31
5.7 BCML GmbH Company Overview 33
5.7.1 BCML GmbH Pipeline Products & Ongoing Clinical Trials Overview 33
5.8 BioCeps (Inactive) Company Overview 34
5.8.1 BioCeps (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 34
5.9 CardioDx, Inc. Company Overview 35
5.9.1 CardioDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
5.10 Celera Corporation Company Overview 37
5.10.1 Celera Corporation Pipeline Products & Ongoing Clinical Trials Overview 37
5.11 Celula, Inc. Company Overview 41
5.11.1 Celula, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
5.12 Children’s Hospital Boston Company Overview 42
5.12.1 Children’s Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 42
5.13 China Medical Technologies, Inc. Company Overview 45
5.13.1 China Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 45
5.14 Da An Gene Co., Ltd. Company Overview 48
5.14.1 Da An Gene Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 48
5.15 Dana-Farber Cancer Institute, Inc. Company Overview 51
5.15.1 Dana-Farber Cancer Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
5.16 Epinex Diagnostics Incorporated Company Overview 53
5.16.1 Epinex Diagnostics Incorporated Pipeline Products & Ongoing Clinical Trials Overview 53
5.17 Genentech, Inc. Company Overview 54
5.17.1 Genentech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 54
5.18 German Cancer Research Center Company Overview 55
5.18.1 German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview 55
5.19 GILUPI Nanomedizin Company Overview 57
5.19.1 GILUPI Nanomedizin Pipeline Products & Ongoing Clinical Trials Overview 57
5.20 Hadassah Medical Center Company Overview 58
5.20.1 Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 58
5.21 Helicos BioSciences Corporation Company Overview 59
5.21.1 Helicos BioSciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 59
5.22 Illumina, Inc. Company Overview 60
5.22.1 Illumina, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60
5.23 IntegraGen SA Company Overview 62
5.23.1 IntegraGen SA Pipeline Products & Ongoing Clinical Trials Overview 62
5.24 Interleukin Genetics, Inc. Company Overview 64
5.24.1 Interleukin Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 64
5.25 JS Genetics Inc. Company Overview 66
5.25.1 JS Genetics Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
5.26 Laboratory Corporation of America Holdings Company Overview 67
5.26.1 Laboratory Corporation of America Holdings Pipeline Products & Ongoing Clinical Trials Overview 67
5.27 Laval University Company Overview 69
5.27.1 Laval University Pipeline Products & Ongoing Clinical Trials Overview 69
5.28 LifeCodexx AG Company Overview 70
5.28.1 LifeCodexx AG Pipeline Products & Ongoing Clinical Trials Overview 70
5.29 Maastricht University Medical Center Company Overview 71
5.29.1 Maastricht University Medical Center Pipeline Products & Ongoing Clinical Trials Overview 71
5.30 Massachusetts Eye and Ear Infirmary Company Overview 72
5.30.1 Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview 72
5.31 Medical Research Council Company Overview 74
5.31.1 Medical Research Council Pipeline Products & Ongoing Clinical Trials Overview 74
5.32 Micromedic Technologies Ltd Company Overview 75
5.32.1 Micromedic Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 75
5.33 Multiplicom N.V. Company Overview 76
5.33.1 Multiplicom N.V. Pipeline Products & Ongoing Clinical Trials Overview 76
5.34 Myriad Genetics, Inc. Company Overview 78
5.34.1 Myriad Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 78
5.35 Natera, Inc. Company Overview 80
5.35.1 Natera, Inc. Pipeline Products & Ongoing Clinical Trials Overview 80
5.36 National University of Singapore Company Overview 85
5.36.1 National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview 85
5.37 NewGene Ltd Company Overview 89
5.37.1 NewGene Ltd Pipeline Products & Ongoing Clinical Trials Overview 89
5.38 NX PharmaGen Inc. Company Overview 94
5.38.1 NX PharmaGen Inc. Pipeline Products & Ongoing Clinical Trials Overview 94
5.39 Paragon Medical, Inc. Company Overview 95
5.39.1 Paragon Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 95
5.40 Population Diagnostics Inc. Company Overview 96
5.40.1 Population Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 96
5.41 Qiagen N.V. Company Overview 100
5.41.1 Qiagen N.V. Pipeline Products & Ongoing Clinical Trials Overview 100
5.42 Quantamerix Company Overview 102
5.42.1 Quantamerix Pipeline Products & Ongoing Clinical Trials Overview 102
5.43 Sapien Biosciences Company Overview 103
5.43.1 Sapien Biosciences Pipeline Products & Ongoing Clinical Trials Overview 103
5.44 Seegene, Inc. Company Overview 104
5.44.1 Seegene, Inc. Pipeline Products & Ongoing Clinical Trials Overview 104
5.45 Sequenom, Inc. Company Overview 106
5.45.1 Sequenom, Inc. Pipeline Products & Ongoing Clinical Trials Overview 106
5.46 Stanford University Company Overview 112
5.46.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 112
5.47 The Johns Hopkins University Company Overview 114
5.47.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 114
5.48 The Sheba Medical Center Company Overview 115
5.48.1 The Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview 115
5.49 The University of Utah Company Overview 116
5.49.1 The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 116
5.50 TrovaGene, Inc. Company Overview 117
5.50.1 TrovaGene, Inc. Pipeline Products & Ongoing Clinical Trials Overview 117
5.51 University of Colorado Company Overview 121
5.51.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 121
5.52 University of Washington Company Overview 122
5.52.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview 122
5.53 VitaPath Genetics, Inc. Company Overview 123
5.53.1 VitaPath Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 123
5.54 Xiamen Zeesan Biotech Co.,Ltd Company Overview 124
5.54.1 Xiamen Zeesan Biotech Co.,Ltd Pipeline Products & Ongoing Clinical Trials Overview 124
5.55 Yale University Company Overview 125
5.55.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview 125
6 Inborn Gene or Chromosome Alterations- Recent Developments 126
7 Appendix 165
7.1 Methodology 165
7.2 About GlobalData 167
7.3 Contact Us 168
7.4 Disclaimer 168


【レポート販売概要】

■ タイトル:世界における先天的遺伝子変異または先天的染色体変異検査製品のパイプライン動向2015
■ 英文:Inborn Gene or Chromosome Alterations - Pipeline Review, 2015
■ 発行日:2015年10月1日
■ 調査会社:GlobalData
■ 商品コード:GDME0076EPD
■ 調査対象地域:グローバル
  • グライコミクス/糖鎖生物学の世界市場分析:製品別(酵素、キット、試薬、機器)、用途別(創薬および開発、診断)、エンドユーザー別、セグメント予測、2014-2025
    The global glycomics/glycobiology market is expected to reach USD 2.1 billion by 2025, according to a new report by Grand View Research, Inc. Increasing investment in R&D by research institutes and pharmaceutical & biotechnology companies has been a major factor driving market growth. In addition, technological advancement has led to increased demand for advanced glycomics products for drug discov …
  • 契約管理ソフトウェアの世界市場予測(~2024年)
    Changes in compliance to drive the demand for contract management softwareMarketsandMarkets projects the contract management software market to grow from USD 1.5 billion in 2019 to USD 2.9 billion by 2024 at a Compound Annual Growth Rate (CAGR) of 13.5% from 2019 to 2024. Major factors expected to drive the growth of the contract management software market include rising demand for an agile contra …
  • Renegade Petroleum Ltd.:石油・ガスの開発・生産動向及びコスト分析- 2012
    Renegade Petroleum Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary Renegade Petroleum Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source …
  • 空圧用シールの世界市場2017-2021:シリンダ用シール、バルブ用シール
    About Pneumatic Seals Pneumatic seals are used in pneumatic components like cylinders and valves that are used in applications that involve rotary or reciprocating motions. The seals are used in devices or components that work in low pressure. Minimal lubrication is used in pneumatic seals to ensure a tight seal so that they can be used in devices or components that are exposed to high operating s …
  • 電動芝刈機の世界市場
    About Electric Lawn MowerElectric lawn mowers are used to maintain lawn areas by mowing and mulching the grass. These mowers are powered by electricity or batteries Technavio’s analysts forecast the global electric lawn mower market to grow at a CAGR of 5.79% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the growth prospects of the global electric …
  • 無菌包装のグローバル市場動向(~2018)
    The aseptic packaging market is experiencing renewed demand due to the flourishing pharmaceutical sector and the growing global dairy industry. This report estimates the market value and volume of aseptic packaging, by types and applications. In terms of geography, the report is segmented into Asia-Pacific, Europe, North America, and Rest of the World (ROW). The aseptic packaging market is broadly …
  • アメリカのデータセンター建設市場2016
    About Data Center Construction Market in the US 2016-2020 The construction of a data center encompasses design, architecture, installation of electrical and mechanical systems, and general building works. The US is a suitable location for data center construction due to benefits such as low electricity cost, high network connectivity, tax incentives, ease of business operations, and availability o …
  • 世界のバイク用ホーン市場2015
    The Global Motorcycle Horn Industry Report 2015 is a professional and in-depth study on the current state of the Motorcycle Horn industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Motorcycle Horn market analysis is provided for the international markets including development trends, competitive lands …
  • カルナウバ蝋の世界市場分析:用途別(タイプ1、タイプ3、タイプ4)、用途別(化粧品、食品、自動車、医薬品)、セグメント予測
    The global carnauba wax market size is expected to reach USD 334.9 million by 2024, according to a new report by Grand View Research, Inc. The market is expected to witness high growth owing to increasing use of the product as a food glazing agent which provides a superior shine, thus improving its aesthetic ability. Carnauba wax market is highly influenced by the favorable regulations enforced by …
  • 屋内ロケーションベースサービス(LBS)の世界市場:製品別、技術別(RFID・NFC、Wi-Fi/WLAN・BT/BLE)、用途別(トラッキング、近接、ナビゲーション)、最終用途別、セグメント予測
    The global indoor lbs market size is expected to reach USD 18.74 billion by 2025, according to a new study by Grand View Research, Inc., rising at a CAGR of 43.3% during the forecast period. Growing use of location-based services in the retail industry for marketing applications in expected to stimulate the growth of the market over the forecast period. Industry players are increasingly striving t …
  • ブドウ膜炎:グローバル臨床試験レビューH2, 2013
    Uveitis Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Uveitis Global Clinical Trials Review, H2, 2013" provides data on the Uveitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Uveitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conductio …
  • 世界の抗菌薬市場(2014-2024)
    Antibacterials - new analysis showing business trends, R&D, and revenue forecasts What's the future of medicines treating bacterial infections? For those drugs you get new sales predictions, also exploring research and development. Those treatments hold high potentials. There you assess results, progress, therapies, and opportunities. Knowledge facilitates success. Visiongain's new report forecast …
  • 世界のウェアラブル医療機器市場
    Wearable medical devices are non-invasive, autonomous health tools, which aid in clinical monitoring beyond the hospitals. The applications of wearables range from monitoring glucose levels in blood, to managing chronic diseases such as heart diseases, asthma and diabetes. These devices generally provide noninvasive sensing, local processing, user feedback, and communication capabilities. In the l …
  • OTC整形外科用ブレースの世界市場予測(~2021年)
    The global OTC orthopedic braces market is estimated to reach USD 1.33 Billion by 2021, growing at a CAGR of 4.8% during the forecast period of 2016 to 2021. Factors such as the growing demand for orthopedic braces among the geriatric population, rising incidence of bone-degenerative diseases, increasing global burden for obesity, ongoing commercialization of orthopedic bracing and support product …
  • アメリカの食品加工機械市場
    About Food Processing Industry The food processing industry is being transformed into a high-volume industry, especially the baked food sector. The industrial baking processing machinery segment is gaining prominence over all other segments, and accounts for the largest portion of the overall sales revenue. This trend is expected to gain further traction during the forecast period, as players are …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。